Improved Photodynamic Efficacy of Zn(II) Phthalocyanines via Glycerol Substitution

Phthalocyanines are excellent photosensitizers for photodynamic therapy as they have strong absorbance in the near infra-red region which is most relevant for in vivo activation in deeper tissular regions. However, most phthalocyanines present two major challenges, ie, a strong tendency to aggregate and low water-solubility, limiting their effective usage clinically. In the present study, we evaluated the potential enhancement capability of glycerol substitution on the photodynamic properties of zinc (II) phthalocyanines (ZnPc). Three glycerol substituted ZnPc, 1–3, (tetra peripherally, tetra non-peripherally and mono iodinated tri non-peripherally respectively) were evaluated in terms of their spectroscopic properties, rate of singlet oxygen generation, partition coefficient (log P), intracellular uptake, photo-induced cytotoxicity and vascular occlusion efficiency. Tetrasulfonated ZnPc (ZnPcS4) was included as a reference compound. Here, we showed that 1–3 exhibited 10–100 nm red-shifted absorption peaks with higher molar absorptivity, and at least two-fold greater singlet oxygen generation rates compared to ZnPcS4. Meanwhile, phthalocyanines 1 and 2 showed more hydrophilic log P values than 3 consistent with the number of glycerol attachments but 3 was most readily taken up by cells compared to the rest. Both phthalocyanines 2 and 3 exhibited potent phototoxicity against MCF-7, HCT-116 and HSC-2 cancer cell-lines with IC50 ranging 2.8–3.2 µM and 0.04–0.06 µM respectively, while 1 and ZnPcS4 (up to 100 µM) failed to yield determinable IC50 values. In terms of vascular occlusion efficiency, phthalocyanine 3 showed better effects than 2 by causing total occlusion of vessels with diameter <70 µm of the chorioallantoic membrane. Meanwhile, no detectable vascular occlusion was observed for ZnPcS4 with treatment under similar experimental conditions. These findings provide evidence that glycerol substitution, in particular in structures 2 and 3, is able to improve the photodynamic properties of ZnPc.

[1]  M. Laranjo,et al.  Halogen atom effect on photophysical and photodynamic characteristics of derivatives of 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin. , 2008, Journal of photochemistry and photobiology. B, Biology.

[2]  Z. Bıyıklıoğlu,et al.  Peripheral and non-peripheral long-chain tetrasubstituted phthalocyanines: Synthesis, spectroscopic characterization and aggregation properties , 2012 .

[3]  T. Nyokong,et al.  Synthesis and photophysical properties of peripherally and non-peripherally mercaptopyridine substituted metal free, Mg(II) and Al(III) phthalocyanines. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[4]  R. Gurny,et al.  State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.

[5]  Tebello Nyokong,et al.  Synthetic pathways to water-soluble phthalocyanines and close analogs , 2010 .

[6]  B. Röder,et al.  Preparation and photophysical properties of halogenated silicon(IV) phthalocyanines substituted axially with poly(ethylene glycol) chains , 2003 .

[7]  T. Nyokong,et al.  Synthesis of zinc phthalocyanine derivatives with improved photophysicochemical properties in aqueous media , 2010 .

[8]  T. Nyokong,et al.  The syntheses and photophysical properties of 4,4′-isopropylidendioxydiphenyl substituted ball-type dinuclear Mg(II) and Zn(II) phthalocyanines , 2012 .

[9]  C. M. Allen,et al.  Photodynamic therapeutics: basic principles and clinical applications. , 1999, Drug discovery today.

[10]  M. Reed,et al.  The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.

[11]  J. E. Lier,et al.  Preparation of amphiphilic glycerol-substituted zinc phthalocyanines using copper-free Sonogashira cross-coupling in aqueous medium , 2011 .

[12]  Tebello Nyokong,et al.  Effects of substituents on the photochemical and photophysical properties of main group metal phthalocyanines , 2007 .

[13]  T. Nyokong,et al.  The renaissance in optical spectroscopy of phthalocyanines and other tetraazaporphyrins , 2004 .

[14]  A. Gonsalves,et al.  Heavy-atom effects on metalloporphyrins and polyhalogenated porphyrins , 2002 .

[15]  J. E. Lier,et al.  Structure‐Photodynamic Activity Relationships of a Series of 4‐Substituted Zinc Phthalocyanines , 1996, Photochemistry and photobiology.

[16]  H. Bergh,et al.  A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. , 2001, Investigative ophthalmology & visual science.

[17]  C. Sibata,et al.  Photosensitizers in clinical PDT. , 2004, Photodiagnosis and photodynamic therapy.

[18]  V. Ahsen,et al.  Glycerol and galactose substituted zinc phthalocyanines. Synthesis and photodynamic activity , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[19]  Devrim Atilla,et al.  A set of highly water-soluble tetraethyleneglycol-substituted Zn(II) phthalocyanines: synthesis, photochemical and photophysical properties, interaction with plasma proteins and in vitro phototoxicity. , 2011, Dalton transactions.

[20]  Aijian Wang,et al.  Synthesis and properties of photo-activable phthalocyanines: a brief overview , 2011 .

[21]  Claudio H. Sibata,et al.  Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.

[22]  K. Ohkubo,et al.  In vitro heavy-atom effect of palladium(II) and platinum(II) complexes of pyrrolidine-fused chlorin in photodynamic therapy. , 2009, Journal of medicinal chemistry.

[23]  Michael R Hamblin,et al.  In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. , 2010, Journal of medicinal chemistry.

[24]  T. Nyokong,et al.  Synthesis and Pd(II) binding studies of octasubstituted alkyl thio derivatised phthalocyanines , 2009 .

[25]  D. A. Russell,et al.  Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse’ , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[26]  J. Miller.  FLUORESCENCE | Quantitative Analysis , 2005 .

[27]  T. Nyokong,et al.  In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy. , 2011, Journal of photochemistry and photobiology. B, Biology.

[28]  R. Puddephatt,et al.  A strongly fluorescent organoplatinum complex , 1995 .

[29]  D. Bruce,et al.  Synthesis of cyclometallated platinum complexes with substituted thienylpyridines and detailed characterization of their luminescence properties. , 2009, Inorganic chemistry.

[30]  Brown,et al.  Photosensitising drugs - their potential in oncology. , 1999, Expert opinion on investigational drugs.

[31]  G. Wagnières,et al.  The Neovessel Occlusion Efficacy of 151‐Hydroxypurpurin‐7‐Lactone Dimethyl Ester Induced with Photodynamic Therapy , 2010, Photochemistry and photobiology.

[32]  William M Gallagher,et al.  In vitro demonstration of the heavy-atom effect for photodynamic therapy. , 2004, Journal of the American Chemical Society.

[33]  R. Lambert,et al.  Long-term survival after photodynamic therapy for esophageal cancer. , 1995, Gastroenterology.

[34]  R. Langlois,et al.  Photodynamic Properties of Amphiphilic Derivatives of Aluminum Tetrasulfophthalocyanine¶ , 2002, Photochemistry and photobiology.

[35]  A. Hajri,et al.  In Vitro and In Vivo Efficacy of Photofrin® and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells¶ , 2002, Photochemistry and photobiology.

[36]  V. Ahsen,et al.  Comparative studies of photophysical and photochemical properties of solketal substituted platinum(II) and zinc(II) phthalocyanine sets , 2010 .

[37]  Patrycja Nowak-Sliwinska,et al.  In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. , 2010, Journal of medicinal chemistry.

[38]  H. van den Bergh,et al.  Like a Bolt from the Blue: Phthalocyanines in Biomedical Optics , 2011, Molecules.

[39]  Hong-Boon Lee,et al.  A New Naturally Derived Photosensitizer and Its Phototoxicity on Head and Neck Cancer Cells , 2011, Photochemistry and photobiology.